DE602005018375D1 - Aufgereinigte arabinogalactanprotein-(agp-)zusammensetzung - Google Patents

Aufgereinigte arabinogalactanprotein-(agp-)zusammensetzung

Info

Publication number
DE602005018375D1
DE602005018375D1 DE602005018375T DE602005018375T DE602005018375D1 DE 602005018375 D1 DE602005018375 D1 DE 602005018375D1 DE 602005018375 T DE602005018375 T DE 602005018375T DE 602005018375 T DE602005018375 T DE 602005018375T DE 602005018375 D1 DE602005018375 D1 DE 602005018375D1
Authority
DE
Germany
Prior art keywords
arabinogalactanprotein
agp
cleaned
composition
cleaned arabinogalactanprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005018375T
Other languages
English (en)
Inventor
Sudershan Kumar Arora
Vandita Srivastava
Sameer Shankar Walunj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of DE602005018375D1 publication Critical patent/DE602005018375D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE602005018375T 2004-09-01 2005-04-26 Aufgereinigte arabinogalactanprotein-(agp-)zusammensetzung Expired - Fee Related DE602005018375D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/931,814 US7601368B2 (en) 2004-09-01 2004-09-01 Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders
PCT/IN2005/000132 WO2006025068A1 (en) 2004-09-01 2005-04-26 A purified arabinogalactan-protein (agp) composition

Publications (1)

Publication Number Publication Date
DE602005018375D1 true DE602005018375D1 (de) 2010-01-28

Family

ID=35943518

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005018375T Expired - Fee Related DE602005018375D1 (de) 2004-09-01 2005-04-26 Aufgereinigte arabinogalactanprotein-(agp-)zusammensetzung

Country Status (19)

Country Link
US (4) US7601368B2 (de)
EP (1) EP1789439B1 (de)
JP (1) JP2008511613A (de)
KR (1) KR20070059062A (de)
CN (1) CN101044161A (de)
AP (1) AP2007003929A0 (de)
AT (1) ATE452142T1 (de)
AU (1) AU2005278780A1 (de)
BR (1) BRPI0514347A (de)
CA (1) CA2577134A1 (de)
DE (1) DE602005018375D1 (de)
EA (1) EA012208B1 (de)
IL (1) IL181230A0 (de)
MX (1) MX2007002428A (de)
NO (1) NO20071120L (de)
TN (1) TNSN07079A1 (de)
UA (1) UA86986C2 (de)
WO (1) WO2006025068A1 (de)
ZA (1) ZA200701311B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
FR2938192B1 (fr) 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
US20120128597A1 (en) * 2008-08-16 2012-05-24 Forschungszentrum Borstel Composition for prevention and treatment of allergic and/or inflammatory diseases
AU2011249145B2 (en) 2010-05-05 2013-05-23 Comvita New Zealand Limited Immunostimulatory compositions and methods of use thereof
FR2975004B1 (fr) * 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
ITMI20112216A1 (it) 2011-12-05 2013-06-06 Fond Salvatore Maugeri Clinic A Del Lavoro E Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee
WO2014190398A1 (en) * 2013-05-31 2014-12-04 The University Of Melbourne Inhibition of amyloid fibril formation
EP3176175B1 (de) 2015-12-01 2020-07-01 Ruhr-Universität Bochum Verfahren zur synthetischen herstellung von arabinogalactanverbindungen, die abgeleitet sind von pflanzen und verwendung der verbindungen zur prophylaxe von allergischen reaktionen
US11179407B2 (en) 2015-12-01 2021-11-23 Forschungszentrum Borstel Leibniz-Zentrum Für Medizin Und Biowissenshaften Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
US10973858B2 (en) 2016-02-12 2021-04-13 Laimu Corporation Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
JP6230638B2 (ja) * 2016-02-12 2017-11-15 株式会社らいむ 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
JP3177642B2 (ja) * 1991-09-10 2001-06-18 ライオン株式会社 抗男性ホルモン剤
WO2001000682A1 (en) 1999-06-30 2001-01-04 Pharmagenesis, Inc. Hematopoietic arabinogalactan composition
EP1467745A2 (de) * 2002-01-10 2004-10-20 Lupin Limited Pflanzliche zusammensetzung zur behandlung verschiedener funktionsstörungen einschliesslich psoriasis, entsprechendes herstellungsverfahren und behandlungsmethode für derartige funktionsstörungen

Also Published As

Publication number Publication date
TNSN07079A1 (en) 2008-06-02
EA012208B1 (ru) 2009-08-28
CA2577134A1 (en) 2006-03-09
US20090264341A1 (en) 2009-10-22
EP1789439A1 (de) 2007-05-30
AP2007003929A0 (en) 2007-02-28
IL181230A0 (en) 2007-07-04
US20100330650A1 (en) 2010-12-30
BRPI0514347A (pt) 2008-06-10
US20090270330A1 (en) 2009-10-29
MX2007002428A (es) 2007-05-11
ZA200701311B (en) 2009-08-26
WO2006025068A1 (en) 2006-03-09
US20060045930A1 (en) 2006-03-02
EA200700532A1 (ru) 2007-08-31
KR20070059062A (ko) 2007-06-11
ATE452142T1 (de) 2010-01-15
EP1789439B1 (de) 2009-12-16
JP2008511613A (ja) 2008-04-17
UA86986C2 (ru) 2009-06-10
US7601368B2 (en) 2009-10-13
CN101044161A (zh) 2007-09-26
WO2006025068A8 (en) 2006-04-20
NO20071120L (no) 2007-05-14
AU2005278780A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
BRPI0613033A2 (pt) composição oral
ATE469205T1 (de) Reinigungszusammensetzungen
NO20055686D0 (no) Sammensetning
DK1898744T3 (da) Tandbørste
ATE500314T1 (de) Waschmittelzusammensetzungen
DE112006004277A5 (de) Glaszusammensetzung
FR2862654B1 (fr) Composition amylacee filmogene
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
DE602005018375D1 (de) Aufgereinigte arabinogalactanprotein-(agp-)zusammensetzung
ATE452173T1 (de) Verbesserungen bei der reinigung
DE502006006590D1 (de) Biozide zusammensetzungen
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
FR2881342B1 (fr) Composition demaquillante
DE602005024486D1 (de) Anthrapyridonfarbstoffe
DE602006011271D1 (de) Anthelminthische zusammensetzung
FR2873289B1 (fr) Composition de nettoyage moussante
SE0302495L (sv) Transportkomposition
FR2890858B1 (fr) Composition demaquillante
FR2871686B1 (fr) Composition anti-decoloration
ATE365529T1 (de) Schweisshemmende zusammensetzungen
NO20042027D0 (no) Oral composition
DK1787516T3 (da) Kiminhiberende sammensætning
FR2873290B1 (fr) Composition de nettoyage moussante
SE0400205D0 (sv) Composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee